MICROSATELLITH INSTABILITY IN ENDOMETRIAL CANCER: DETECTION WITH IMMUNOHISTOCHEMICAL MARKERS AND ITS RELATIONSHIP WITH CLINICAL OUTCOME

被引：0
|
作者：
Kamalli, Goncha [1 ]
Sirma, Tugce [1 ]
Akman, Levent [1 ]
Serin, Gurdeniz [1 ]
Terek, Mustafa Cosan [1 ]
机构：
[1] Ege Univ, Fac Med, Izmir, Turkiye
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
关键词：
D O I：
10.1136/ijgc-2023-ESGO.355
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
629
引用
收藏
页码：A172 / A173
页数：2
相关论文
共 50 条
  • [21] Immunohistochemical Detection of WT1 Protein in Endometrial Cancer
    Ohno, Satoshi
    Dohi, Satoshi
    Ohno, Yumiko
    Kyo, Satoru
    Sugiyama, Haruo
    Suzuki, Nobutaka
    Inoue, Masaki
    ANTICANCER RESEARCH, 2009, 29 (05) : 1691 - 1695
  • [22] Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review
    Travaglino, Antonio
    Raffone, Antonio
    Saccone, Gabriele
    Insabato, Luigi
    Mollo, Antonio
    De Placido, Giuseppe
    Zullo, Fulvio
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2019, 98 (09) : 1086 - 1099
  • [23] Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer
    Laas, Enora
    Ballester, Marcos
    Cortez, Annie
    Gonin, Julie
    Dargai, Emile
    Graesslin, Olivier
    GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 205 - 210
  • [24] Clinical Correlations between Serological Markers and Endometrial Cancer
    Marin, Alina-Gabriela
    Filipescu, Alexandru George
    Petca, Razvan Cosmin
    Vladareanu, Radu
    Petca, Aida
    CANCERS, 2024, 16 (10)
  • [25] Predicting recurrence in endometrial cancer based on a combination of classical parameters and immunohistochemical markers
    Jiang, P.
    Huang, J.
    Hu, Z.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 37 - 37
  • [26] Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer
    Kudela, M.
    Pilka, R.
    Lubusky, M.
    Hejtmanek, P.
    Dzubak, P.
    Brychtova, S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (02) : 159 - 163
  • [27] Unsupervised Clustering of Immunohistochemical Markers to Define High-Risk Endometrial Cancer
    Laas, Enora
    Ballester, Marcos
    Cortez, Annie
    Graesslin, Olivier
    Darai, Emile
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (02) : 461 - 469
  • [28] Predicting Recurrence in Endometrial Cancer Based on a Combination of Classical Parameters and Immunohistochemical Markers
    Jiang, Peng
    Huang, Jin
    Deng, Ying
    Hu, Jing
    Huang, Zhen
    Jia, Mingzhu
    Long, Jiaojiao
    Hu, Zhuoying
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 7395 - 7403
  • [29] Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markers
    Wong, YF
    Cheung, TH
    Lo, KWK
    Yim, SF
    Chan, LKY
    Buhard, O
    Duval, A
    Chung, TKH
    Hamelin, R
    CARCINOGENESIS, 2006, 27 (05) : 951 - 955
  • [30] The relationship between oncogene expression and clinical outcome in endometrial carcinoma
    Takai, N
    Ueda, T
    Nishida, M
    Nasu, K
    Miyakawa, I
    CURRENT CANCER DRUG TARGETS, 2004, 4 (06) : 511 - 520
12345